𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiovascular death in rheumatoid arthritis: A population-based study

✍ Scribed by Hilal Maradit-Kremers; Paulo J. Nicola; Cynthia S. Crowson; Karla V. Ballman; Sherine E. Gabriel

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
95 KB
Volume
52
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Glucocorticoids and cardiovascular event
Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population-based cohort study
✍ John M. Davis III; Hilal Maradit Kremers; Cynthia S. Crowson; Paulo J. Nicola; K πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 2 views

## Abstract ## Objective To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA). ## Methods A total of 603 adult residents of Rochester, Minnesota with incident RA between 1955 and 1995 were followed up through thei

High ten-year risk of cardiovascular dis
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study
✍ Hilal Maradit Kremers; Cynthia S. Crowson; Terry M. Therneau; Veronique L. Roger πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract ## Objective To estimate the 10‐year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors to absolute risk assessment. ## Methods A population‐based incidence cohort of RA patients (defined

Gaps in care for rheumatoid arthritis: A
Gaps in care for rheumatoid arthritis: A population study
✍ Lacaille, Diane ;Anis, Aslam H. ;Guh, Daphne P. ;Esdaile, John M. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Abstract ## Objective Treatment guidelines for rheumatoid arthritis (RA) now recommend early, aggressive, and persistent use of disease‐modifying antirheumatic drugs (DMARDs) to prevent joint damage in all people with active inflammation, and evaluation by a rheumatologist, when possible. This